Financials
- Market Capitalization 2.31 B
- Employee 647
- Founded 2004
- CEO N/A
- Website www.admabiologics.com
- Headquarter Delaware, United States
- FIGI BBG002NCK5M5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
30.4
Rapporto prezzo/fatturato
8.76
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1819 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 20.19 USD | -4.99% | -8.14% | -9.54% | -44.33% | 2.41 B USD | ||
| 1825 | LQDA Liquidia Corporation - Common Stock | 26.81 USD | -3.11% | +4.69% | -58.95% | +18.63% | 2.40 B USD | ||
| 1876 | CLDX Celldex Therapeutics, Inc. - Common Stock | 28.25 USD | -4.01% | -7.74% | -27.56% | +3.71% | 2.22 B USD | ||
| 1885 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.36 USD | -1.15% | +5.14% | +0.06% | +37.13% | 2.18 B USD |